RVBA-ELACPharma Manufacturing

Eli Lilly and Company — in detail

Full extracted data, every event in the company's history we've captured, and (soon) external news. The full ratios diagnostic with peer benchmarks lives at /ratios.

Reference sources (2/5)

Source documents
Recent disclosure
Multi-year metrics
Targets
Certifications

External news· 3 ESG-tagged · GDELT

tagged categories: climate · governance · controversy · M&A · regulatory

Source: GDELT 2.0 DOC API · ESG-keyword filtered · 3-month trailing window.

Data by year· every metric + key events per year

Each year shows the firm's reported metrics on the left and the most material events on the right. Up to 10 events per year; the full event log is one click further.

2025

P&L highlights (USD)

Headcount (FTE)	50,000people
Revenue	65.2B
Cost of revenue	(10.6B)
Gross profit	54.6B
Operating expenses (S&M + G&A)	(24.9B)
Operating income	29.7B
Net income	20.6B

Balance sheet highlights (USD)

Property, plant & equipment	24.7B
Total assets	112.5B
Total debt	42.5B
Cash & equivalents	7.2B
Minority interest	0

Market & shares

Market cap (FY-end)	965.1B
Shares outstanding	898M

2024

cdp response ↗

P&L highlights (USD)

Headcount (FTE)	47,000people
Revenue	45B
Cost of revenue	(8.4B)
Gross profit	36.6B
Operating expenses (S&M + G&A)	(19.1B)
Operating income	17.5B
Net income	10.6B

Balance sheet highlights (USD)

Property, plant & equipment	17.1B
Total assets	78.7B
Total debt	33.6B
Cash & equivalents	3.3B
Minority interest	79.5M

Market & shares

Market cap (FY-end)	695.3B
Shares outstanding	900.6M

2023

cdp response ↗

Climate · carbon footprint (tCO2e)

Scope 1	182,000
Scope 2 (market-based)	345,000
Scope 3	5M
Cat 1 · Purchased goods	3.1M
Cat 6 · Business travel	40,500
Cat 7 · Employee commuting	45,100
Cat 15 · Investments	4,800
Gross carbon footprint	5.5M
Net carbon footprint	5.5M

Energy (kWh)

Renewable energy %

28%

P&L highlights (USD)

Headcount (FTE)	43,000people
Revenue	34.1B
Cost of revenue	(7.1B)
Gross profit	27B
Operating expenses (S&M + G&A)	(16.3B)
Operating income	10.8B
Net income	5.2B

Balance sheet highlights (USD)

Property, plant & equipment	12.9B
Total assets	64B
Total debt	25.2B
Cash & equivalents	2.8B
Minority interest	91.8M

Market & shares

Market cap (FY-end)	524.3B
Shares outstanding	899.4M

Events 2023· 3

New North Carolina manufacturing facility startup

Startup of a new manufacturing facility in Research Triangle Park, North Carolina increased 2023 energy consumption and partially offset emissions reductions from energy efficiency and renewable electricity. Two new sites also being purchased and four new manufacturing plants under construction, expected to increase future water and emissions footprint.

▾ expand

Limited assurance (ISAE 3000) on Scope 1, 2 and 3

Lilly obtained third-party limited assurance per ISAE 3000 covering 100% of reported Scope 1, Scope 2 (location and market-based), and all reported Scope 3 categories.

▾ expand

Large increase in Scope 3 Cat 6 business travel emissions

Business travel emissions rose from 8,581 tCO2e (2021 base year) to 40,500 tCO2e in 2023 — ~4.7x increase, reflecting post-COVID return to travel. Includes air, road (non-company cars), and rail.

▾ expand

2022

cdp response ↗

Climate · carbon footprint (tCO2e)

Scope 1	171,000
Scope 2 (market-based)	374,000
Scope 3	3.2M
Cat 1 · Purchased goods	2.1M
Cat 6 · Business travel	22,400
Cat 7 · Employee commuting	33,440
Cat 15 · Investments	10
Gross carbon footprint	3.7M
Net carbon footprint	3.7M

Energy (kWh)

Renewable energy %

14%

P&L highlights (USD)

Headcount (FTE)	39,000people
Revenue	28.5B
Cost of revenue	(6.6B)
Gross profit	21.9B
Operating expenses (S&M + G&A)	(13.3B)
Operating income	8.7B
Net income	6.2B

Balance sheet highlights (USD)

Property, plant & equipment	10.1B
Total assets	49.5B
Total debt	16.2B
Cash & equivalents	2.1B
Minority interest	125.6M

Market & shares

Market cap (FY-end)	347.6B
Shares outstanding	950.2M

Events 2022· 6

Water-related targets set (PNEC, water efficiency, phosphorus)

Set multiple water targets in 2022 with 2030 horizons: meet PNEC discharge limits at all direct operations and supplier sites; reduce water use intensity 5% per unit production; reduce phosphorus discharge 20% per unit production; maintain 100% WASH services.

▾ expand

Joined RE100 commitment

In 2022, Lilly joined RE100, formalizing its public commitment to 100% renewable electricity by 2030 and providing additional accountability through the global initiative.

▾ expand

First comprehensive Scope 3 inventory across all 15 categories

2021 was the first year Lilly performed a detailed assessment of all relevant categories of Scope 3 emissions. This significantly expanded reported emissions transparency, with Scope 3 representing >80% of total emissions. Note: Cat 2 (capital goods) bundled into Cat 1 due to data limitations.

▾ expand

Puerto Rico cogeneration plant commissioned (fuel switch)

In 2022, Lilly commenced operations of a 9.4 MW combined heat and power system in Puerto Rico, switching from grid electricity to on-site LNG combustion. This shifts emissions between Scope 2 (decreased) and Scope 1 (increased) but yields net 15-20% GHG reduction at the site.

▾ expand

SBTi target anticipated within two years

Lilly's current 2030 carbon neutrality target is not yet a science-based target but the company states it anticipates setting one within the next two years.

▾ expand

Limited third-party assurance over Scope 1, 2 and full Scope 3

Annual third-party limited assurance under ISAE 3000 covering 100% of reported Scope 1, Scope 2 (location and market), and all Scope 3 categories.

▾ expand

2021

Climate · carbon footprint (tCO2e)

Scope 1	157,227
Scope 2 (market-based)	466,000
Scope 3	3M
Cat 1 · Purchased goods	2.4M
Cat 6 · Business travel	8,581
Cat 7 · Employee commuting	25,108
Gross carbon footprint	3.6M
Net carbon footprint	3.6M

Energy (kWh)

Renewable energy %

10%

P&L highlights (USD)

Headcount (FTE)	35,000people
Revenue	28.3B
Cost of revenue	(7.3B)
Gross profit	21B
Operating expenses (S&M + G&A)	(13.1B)
Operating income	7.9B
Net income	5.6B

Balance sheet highlights (USD)

Property, plant & equipment	9B
Total assets	48.8B
Total debt	16.9B
Cash & equivalents	3.8B
Minority interest	175.6M

Market & shares

Market cap (FY-end)	263.4B
Shares outstanding	953.7M

Events 2021· 9

100% renewable electricity target by 2030

New target set in 2021 to secure 100% of purchased electricity from renewable sources by 2030, from 2019 baseline of 6.7%.

▾ expand

Carbon neutrality goal for Scope 1 & 2 by 2030

In 2021, Lilly launched new 2030 climate goals including 100% renewable purchased electricity and carbon neutrality in Scope 1 and 2 operations by 2030 (vs 2019 baseline of 808,506 tCO2e).

▾ expand

Carbon neutral by 2030 target (Scope 1 & 2)

Set target in 2021 for 100% absolute reduction in Scope 1 and Scope 2 market-based emissions by 2030 vs 2019 baseline. Aligned with 1.5°C scenario. Through 2023, achieved 34.86% of target relative to base year (26% absolute reduction in own operations from 2020-2023).

▾ expand

100% renewable electricity by 2030 / RE100 commitment

Set goal to source 100% of purchased electricity from renewable sources by 2030. Became RE100 signatory in 2022. Reached 28.4% in 2023 (185,770 MWh).

▾ expand

Third-party limited assurance extended to Scope 3

Bureau Veritas provided limited assurance (ISAE3000) on Scope 1, Scope 2 (location and market-based), and all Scope 3 categories for 2021 reporting.

▾ expand

2030 climate goals launched: carbon neutrality and 100% renewable electricity

In 2021, Lilly launched new 2030 environmental goals: achieve carbon neutrality in operations (Scope 1 and Scope 2) by 2030 and secure 100% of purchased electricity from renewable sources. Board approved.

▾ expand

First-time Scope 3 inventory baseline (2021)

Lilly established 2021 as base year for Scope 3 categories (purchased goods, capital goods, fuel/energy, transport, waste, business travel, commuting, downstream transport, end-of-life, investments). Investments (Cat 15) were not calculated for prior base year but added from 2021 onwards.

▾ expand

First market-based Scope 2 reporting

2021 is the first year that Lilly calculated and verified market-based Scope 2 emissions reporting.

▾ expand

First full Scope 3 value chain inventory

In 2021, Lilly advanced efforts to track and report full Scope 3 (value-chain) emissions, including all relevant categories. Previous years only included a limited boundary of Scope 3 categories. Base year for Scope 3 set to 2021.

▾ expand

2020

P&L highlights (USD)

Headcount (FTE)	35,000people
Revenue	24.5B
Cost of revenue	(5.5B)
Gross profit	19.1B
Operating expenses (S&M + G&A)	(11.8B)
Operating income	7.2B
Net income	6.2B

Balance sheet highlights (USD)

Property, plant & equipment	8.7B
Total assets	46.6B
Total debt	16.6B
Cash & equivalents	3.7B
Minority interest	183.6M

Market & shares

Market cap (FY-end)	161.5B
Shares outstanding	956.6M